A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly

Wing, Lindon M.H., Reid, Christopher M., Ryan, Philip, Beilin, Lawrence J., Brown, Mark A., Jennings, Garry L.R., Johnston, Colin I., McNeil, John J. +4 more·2003·New England Journal of Medicine
DOI 10.1056/nejmoa021716

Cited by (1,000)

Items 801–900 of 1,000

  1. Are Racial Differences in Antihypertensive Responsiveness Reflected in Usage After Stroke?
    Bruce I Ovbiagele, Nancy K. Hills, Jeffrey L. Saver, S. Claiborne Johnston · 2006 · Journal of Stroke and Cerebrovascular Diseases
  2. Hypertension treatment by primary care physicians in Lagos
    Olagoke Korede Ale, Rotimi Williams Braimoh · 2017 · Nigerian Journal of Cardiology
  3. Therapie der Hypertonie mit Diuretika
    Rainer Düsing · 2011 · Der Internist
  4. Ambulatory blood pressure monitoring: a useful tool to diagnose hypertension and supervise it's treatment.
    B Shrestha, Sachin Dhungel, Sagar Pahari · 2008 · PubMed
  5. The Last Nail in Hydrochlorothiazide's Coffin?
    Firas J. Al Badarin, Carl J. Lavie, James Henry O’Keefe · 2012 · PubMed Central
  6. Is Renin-Based Treatment a Reasonable Strategy to Treat Essential Hypertension?
    Andrea Verhovez, Paolo Mulatero, Chiara Bertello, Elisa Saglio, Andrea Viola, Francesco Tosello, Franco Rabbia, Franco Veglio · 2008 · High Blood Pressure & Cardiovascular Prevention
  7. Drug therapy for prevention of cardiovascular disease – should surrogate measures be abandoned?
    Peter H. Winocour · 2005 · Clinical Medicine
  8. Evidências no tratamento da hipertensão arterial em idosos
    Carlos Eduardo, Paulo Francisco Guerreiro Cardoso, Denise Torejane, Rodrigo Fernando Ghiggi · 2006
  9. Effects of selective imidazolin-1 receptor agonists' vs Dihydropyridine calcium channel blockers on insulin resistance in patients of hypertension with metabolic syndrome: a meta-analysis of randomized controlled trials
    Sharanabasayyaswamy Hiremath, Priya Gandigawad · 2016 · International Journal of Basic & Clinical Pharmacology
  10. Long-Term and Short-Term Changes in Antihypertensive Prescribing by Office-Based Physicians in the United States
    W.J. Elliott · 2007 · Yearbook of Cardiology
  11. Antihypertensive drug treatment and cardiovascular prevention : an update including the 2003–2004 secondary prevention trials
    Jan A. Staessen, Yan Li, Lutgarde Thijs, Wang Jg · 2006 · Lirias
  12. Prevalence, management and control of hypertension in older adults on admission to hospital
    Tariq M. Alhawassi, Ines Krass, Lisa Pont · 2017 · Saudi Pharmaceutical Journal
  13. Type 2 Diabetes
    Ronald B Goldberg · 2006 · Fundamental and clinical cardiology
  14. Chapter 8. Hypertension in the elderly
    2014 · Hypertension Research
  15. Antihypertensive therapies
    Lionel Henry Opie, Henry Krum, Ronald G. Victor, Norman M. Kaplan · 2013 · Elsevier eBooks
  16. Choosing the ideal drug for hypertension after ischemic stroke
    Eduard Rozner, Arnold E. Eggers, Daniel M. Rosenbaum · 2009 · Current Hypertension Reports
  17. Hypertension strategies in the third millennium: conservatism, evidence and the folly of speculation
    Hugh Farrell McIntyre · 2008 · International Journal of Clinical Practice
  18. Benefits of Diuretic-Based Low-Cost Antihypertensive Therapy
    Giovanni DE SIMONE, Oreste DE DIVITIIS · 2005 · High Blood Pressure & Cardiovascular Prevention
  19. Hypertension in the Elderly
    Michael E. Maddens, Khaled Imam, Ayham Ashkar · 2005 · Primary Care Clinics in Office Practice
  20. Relation of Alcohol Consumption to Risk of Heart Failure in Patients Aged 65 to 84 Years With Hypertension
    Berhe Weldearegawi Sahle, Alice J. Owen, Lindon M H Wing, Lawrence Joseph Beilin, Mark Raymond Nelson, Garry Jennings, Christopher Michael Reid · 2018 · The American Journal of Cardiology
  21. Cardiovascular Pharmacology
    Roger L. Royster, Leanne Groban, David W. Grosshans, Mandisa‐Maia Jones, Thomas Slaughter · 2011 · Elsevier eBooks
  22. Blutdruckunabhängige Wirkungen von Antihypertensiva
    Ulrich Otto Wenzel, Günter Wolf · 2005 · Der Internist
  23. Tratamiento farmacol?gico de la hipertensi?n arterial
    P. Ca Gmez, A. Martínez-Berganza, J.I. Pérez Calvo · 2004 · Medicine - Programa de Formación Médica Continuada Acreditado
  24. Real‐World Evidence Supports Optimally Dosed Thiazide‐Type Diuretics As Preferred in Treatment Regimens of Older Adults with Hypertension
    Paula T. Einhorn, Paul Kieran Whelton, Barry R. Davis, Jackson T. Wright, William C. Cushman, Susan J. Zieman · 2015 · Journal of the American Geriatrics Society
  25. Medical Management of Patients with an Acute Stroke: Treatment and Prevention
    Mark J. Alberts · 2003 · Topics in Stroke Rehabilitation
  26. Influencing the natural history of hypertension: is it the blood pressure achieved, the drug, or the drug dose?
    Norman K. Hollenberg · 2008 · Journal of Hypertension
  27. Enfermedad cerebrovascular (I): prevención primaria y diagnóstico
    Manuel Domínguez Sardiña, Francisco Javier García Soidán, Fernando Isidro Lago Deibe · 2005 · FMC - Formación Médica Continuada en Atención Primaria
  28. Bashing diuretics or failure of surrogate endpoint?
    Franz H. Messerli, Olga Kuteyeva · 2007 · Journal of Hypertension
  29. Hipertensión arterial y riesgo cardiovascular en el año 2004
    Vicente Bertoméu, Pedro Morillas Blasco, Federico Soria Arcos, Pilar Mazón Ramos, José Ramón González‐Juanatey, José Luis Palma Gámiz · 2005 · Revista Española de Cardiología Suplementos
  30. Diuretics Are Preferred Over Angiotensin II-Converting Enzyme Inhibitors For Initial Therapy of Uncomplicated Hypertension
    Vito M. Campese · 2007 · American Journal of Kidney Diseases
  31. Hypertonie?Folgen am Endorgan Gehirn
    HC Diener, Th. Philipp, Joachim Schrader · 2003 · Der Internist
  32. Which drug should be used to treat patients with uncomplicated essential hypertension?
    Arash Rashidi, Mahboob Rahman, Jackson T. Wright · 2006 · Current Opinion in Nephrology & Hypertension
  33. Sensible prescribing for older people
    Hilary Wynne · 2003 · Clinical Medicine
  34. Choice of treatment: outcomes and treatment goals
    Robert J. Temple · 2003 · American Heart Journal
  35. Neurohormonal Activation in Populations Susceptible to Heart Failure
    Johan Ärnlöv, Ramachandran Srini Vasan · 2005 · Heart Failure Clinics
  36. Measuring Adherence to Antihypertensive Drug Therapy
    Anna O. D’Souza · 2004 · Journal of Managed Care Pharmacy
  37. MAKING PROGRESS IN STABLE PATIENTS POST STROKE OR TRANSIENT ISCHAEMIC ATTACK: IMPLICATIONS FOR GENERAL PRACTICE
    Graham Jackson · 2003 · International Journal of Clinical Practice
  38. In Reply—The Different Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality
    Sripal Bangalore, Robert J. Fakheri, Bora Toklu, Franz H. Messerli · 2016 · Mayo Clinic Proceedings
  39. Assessing hypertension therapies: randomization or confounding by indication?
    Sverre Erik Kjeldsen, Ingrid Os · 2019 · Nature Reviews Cardiology
  40. Response to the editorial: “the international society of hypertension guidelines 2020 – a new drug treatment recommendation in the wrong direction?”
    Neil R Poulter, Bryan Williams, Aletta Elisabeth Schutte, Thomas Unger · 2020 · Blood Pressure
  41. A Basic Review on Hypertension, its Non-Pharmacological and Pharmacological Treatment
    Anjali Singh, Vishal Vishal, Ankit Kumar, Sonam Sonam, Nitin Kumar, Neelam Sharma · 2024 · Journal of Drug Delivery and Therapeutics
  42. Pharmacotherapy for mild hypertension
    Dominic Wang, James M Wright, Stephen P Adams, David Keith Cundiff, François Gueyffier, Guillaume Grenet, Anshula Ambasta · 2026 · Cochrane Database of Systematic Reviews
  43. Drug Safety and Effectiveness Network Report: A Systematic Review with Network Meta-Analyses and Economic Evaluation Comparing Therapies for Hypertension in Non-Diabetic Patients
    Brian Hutton, Fatemeh Yazdi, Mona Hersi, Ferrán Catalá-López, Jennifer Tetzlaff, Salmaan Kanji, Dean A. Fergusson, Lise M. Bjerre, Doug Coyle, Cathryn Coyle et al. · 2014 · uO Research (University of Ottawa)
  44. Post-marketing surveillance study of valsartan/amlodipine combination in Taiwanese hypertensive patients
    Shu‐Meng Cheng, Guang-Yuan Mar, Shih‐Chung Huang, Chung-Sen Chen, Chih-Min Hsieh, Lien-Chi Huang, Kwo‐Chang Ueng · 2012 · Blood Pressure
  45. VALUE and WALNUT
    Philip R. Liebson · 2004 · Preventive Cardiology
  46. Pharmacological Management of Hypertension in the Elderly - Certitudes and Controversies
    Karolina Piotrowicz, Ewa Kucharska, Anna Skalska, Aleksander Kwater, Seetha Bhagavatula, Jerzy Gąsowski · 2014 · Current Pharmaceutical Design
  47. Eerste keus bij hypertensie: chloortalidon of hydrochloorthiazide?
    Eric Lambermon, Kirsti M. Jakobs, Joukje van Merkestein, Mascha Gesthuizen, Andrew Oostindjer · 2014 · Huisarts en Wetenschap
  48. Hypertension therapy in the oldest patients
    Nigel S Beckett, Dean J. Noimark · 2009 · Current Cardiovascular Risk Reports
  49. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1354 Clinical Manifestations of Coronary Heart Disease and the Metabolic Syndrome A Population-based Study in Middle-aged Men in Uppsala
    Kristina Dunder · 2004
  50. Antihypertensive Therapy in Females: A Clinical Review Across the Lifespan
    Joel C. Marrs, Angela M. Thompson · 2016 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  51. What's New About Old Drugs
    Sunny Anne Linnebur · 2004 · Journal of Gerontological Nursing
  52. Thiazide Intolerance - A New Zealand Perspective
    Walter van der Merwe · 2013 · Journal of Hypertension Open Access
  53. Clinical trials report
    John Alan Farmer · 2007 · Current Atherosclerosis Reports
  54. Le risque cardio-vasculaire
    Claude Pierre Giudicelli, Xavier Chanudet · 2004 · Bulletin de l Académie Nationale de Médecine
  55. Evidence-Based Cardiovascular Disease Prevention: Challenges to Assessing Risk in Office Practice
    GARY E. RUOFF · 2005
  56. Invited review Blood pressure control based on office and ambulatory blood pressure monitoring: the European experience in hypertensive patients treated in clinical practice
    Bernard Waeber, José R. Banegas, Giuseppe Mancia, Luis Miguel Ruilope · 2009 · BOA (University of Milano-Bicocca)
  57. Inhibicja RAAS a śmiertelność w nadciśnieniu tętniczym: od farmakologii do dowodów klinicznych
    Roberto Ferrari · 2013 · Kardiologia Polska
  58. Understanding the Molecular Crosstalk in Biological Processes
    Mohamed Ahmed El-Esawi · 2019 · IntechOpen eBooks
  59. Possibilities of using fosinopril in treatment of patients with chronic kidney disease in combination with cardiovascular diseases and diabetes mellitus
    Elizaveta Yu. Ebzeeva, Ol'ga Dmitrievna Ostroumova, Батюкина Светлана Владимировна, N. A. Shatalova, N. M. Doldo, R. R. Romanovsky · 2021 · Medical alphabet
  60. A Comparative Study of Tolerability of Losartan versus Atenolol in Essential Hypertension and Their Effect on Lipid Profile
    Amrutha Torvi, D Prashanth, S Soujanya, Lingraj Patil · 2021 · Pharmacology and Clinical Pharmacy Research
  61. Management of Hypertension in Older People
    Nay Thu Win, Shyh Poh Teo · 2017 · Journal of the Hong Kong College of Cardiology
  62. Thérapeutique diurétique
    Claire Presne, Matthieu Monge, Janette Mansour, Roxana Oprisiu, Gabriel J. Choukroun, Jean Michel Achard, A. Fournier · 2004 · Encyclopédie médico-chirurgicale. Néphrologie
  63. Deprescribing Antihypertensive Medications in Older People: A Narrative Review, Part 1
    Patrick T. Russell, Campbell Henry Thompson, Arduino Aleksander Mangoni · 2023 · The Senior Care Pharmacist
  64. Introduction of Renin-Angiotensin-Aldosterone System (RAAS)
    Mukesh Nandave · 2024 · Springer eBooks
  65. Frauen mit arterieller Hypertonie
    Anna Mitchell, T Philipp · 2007 · Der Internist
  66. Blood-pressure-related risk factors, stroke, and cognitive function: What are the relationships and what can we do about them?
    Myron H. Weinberger · 2003 · Seminars in Cerebrovascular Diseases and Stroke
  67. What can we expect from new guidelines?
    Norman M. Kaplan · 2004 · Medical Clinics of North America
  68. POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
    А. Г. Евдокимова, Vladimir V. Evdokimov · 2013 · CARDIOVASCULAR THERAPY AND PREVENTION
  69. OLDER PEOPLE WITH CHRONIC KIDNEY DISEASE: DEFINITION, AND INFLUENCE OF BIOMARKERS AND MEDICATIONS UPON CARDIOVASCULAR AND RENAL OUTCOMES
    Maharajan Raman, Darren Green, Rachel Middleton, Philip A. Kalra · 2016 · Journal of Renal Care
  70. Hypertensive Kidney Disease
    Nitin Khosla, Rigas Kalaitzidis, George L. Bakris · 2010 · Elsevier eBooks
  71. Selecting Optimum Antihypertensive Therapy
    Vasilios Papademetriou, Michael N. Doumas · 2016 · Springer eBooks
  72. The Results of the Clinical Trials in Hypertension: Unquestionable Benefits and Limits
    2017 · Journal of Cardiology & Current Research
  73. Effect of Losartan on Different Biochemical Parameters in Essential Hypertensive Patients
    Pratibha Satish Salve, Chitra C. Khanwelkar, Preeti S. Salve, Vandana M Thorat, Somnath M. Matule, S Seshla · 2019 · Biomedical & Pharmacology Journal
  74. Effekter av antihypertensiver på glukosemetabolisme og kardiovaskulære hendelser
    Knud H. Landmark, Åsmund Reikvam · 2009 · Tidsskrift for Den norske legeforening
  75. Prescription Pattern and Blood Pressure Control among Patients on Antihypertensive Medications Attending a Tertiary Hospital in Lagos
    Sunday O. Ogundele, Adeola Olubunmi Ajibare, Mumuni Alade Amisu, Akinola Olusola Dada · 2021 · Nigerian Journal of Basic and Clinical Sciences.
  76. A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension
    Hae‐Young Lee, Kwang‐Il Kim, Sang‐Hyun Ihm, Moo‐Yong Rhee, Il Suk Sohn, Sungha Park, Eun‐Seok Jeon, Jong‐Min Song, Wook Bum Pyun, Ki‐Chul Sung et al. · 2021 · Clinical Therapeutics
  77. Hemmstoffe des Renin-Angiotensin-Systems
    Manfred Anlauf, Franz Weber · 2015 · Springer eBooks
  78. Tratamiento de la hipertensión arterial
    Adriana Sierra · 2006 · Hipertensión
  79. Aportaciones del séptimo informe del Joint National Committee. Seis años después
    J Bayó i Llibre, Gabriel Coll de Tuero, Antoni Dalfó Baqué, Mariano de la Figuera von Wichmann, N. Salleras Marcó, E Vinyoles i Bargalló · 2003 · Atención Primaria
  80. Sex/Gender Differences in Hypertension and Dyslipidemia
    Eun Joo Cho · 2024 · Springer eBooks
  81. Aliskiren in hypertension: evidence for its potential therapeutic value
    Core Journal · 2005 · Core evidence
  82. The Hypertension Guidelines of the Seventh Joint National Committee
    Giuseppe Mancia, Guido M. Grassi · 2004 · High Blood Pressure & Cardiovascular Prevention
  83. ACE-Hemmer und Angiotensinrezeptorantagonisten
    Manfred Anlauf · 2008 · Springer eBooks
  84. [After the ALLHAT trial, what do we know about treatment for hypertension that we did not know before?].
    José Ramón González‐Juanatey · 2003 · PubMed
  85. Predictors of Failure to Initiate Randomized Treatment in a Large Trial of Antihypertensive Drug Therapy in the Aged
    Mark Raymond Nelson, Philip Ryan, Kristyn J. Willson, Christopher Michael Reid, Lawrence Joseph Beilin, Garry Jennings, Colin I. Johnston, Graham J. Macdonald, John E. Marley, John J. McNeil · 2005 · American Journal of Hypertension
  86. Hypertension Treatment and Management Concerns in the Elderly
    Michael J. Fischer · 2009 · Aging Health
  87. Obesity and hypertension: It's about more than the numbers
    Keith C. Ferdinand · 2013 · Obesity
  88. Is There More to Life Than Blood Pressure?
    Michael A. Weber · 2005 · Journal of Clinical Hypertension
  89. Selection of Initial Antihypertensive Therapy, Regimen Design, and Goal Blood Pressure
    Rajiv Agarwal · 2003 · Cardiology in Review
  90. ACE inhibitors reduced cardiovascular events and all cause mortality in elderly people with hypertension
    R. Davidson · 2003 · BMJ Evidence-Based Medicine
  91. Prim�res Antihypertensivum?Diuretika vs. Kalziumantagonisten vs. ACE-Hemmer
    Juergen E. Scholze, Th. Unger · 2002 · Der Internist
  92. Necesidad actual de conocer la efectividad de los medicamentos: La gran oportunidad para los ensayos clínicos pragmáticos
    J. Soto Álvarez · 2005 · PharmacoEconomics Spanish Research Articles
  93. Update in Cardiology
    Elliot Rapaport · 2004 · Annals of Internal Medicine
  94. Building on the Specialist's Antihypertensive Treatment Recommendation: It's Just the Beginning
    Elijah Sounders · 2006 · Journal of Clinical Hypertension
  95. Hypertension in practice: towards the year 2010
    D. Gareth Beevers · 2008 · Therapy
  96. Amlodipine or lisinopril was not better than chlorthalidone in lowering CHD risk in hypertension
    Bruce M. Psaty · 2003 · BMJ Evidence-Based Medicine
  97. Do pleiotropic effects of antihypertensive medications exist or is it all about the blood pressure?
    Domenic A. Sica · 2007 · Current Cardiovascular Risk Reports
  98. Impact of ASCOT on hypertension treatment and guidelines in older adults
    Ray Sheridan, Neil Baldwin · 2006 · Age and Ageing
  99. European Society of Hypertension American Society of Nephrology, Association of Black Cardiologists, and Society for Preventive Cardiology, American Society of Hypertension, American Academy of Neurology, American Geriatrics Society, American Developed in Collaboration With the Clinical Expert Consensus Documents A Report of the American College of Cardiology Foundation Task Force on ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly:
    Deborah J. Wesley, Eduardo Ortíz, Efrain Reisin, Michael W. Rich, Douglas D. Schocken, Michael A. Frishman, Cheryl S. Jaigobin, John B. Kostis, Giuseppi Mancia, Suzanne Oparil et al. · 2011
  100. Hypertension: treating the patient as well as the blood pressure
    Graham Hunter Jackson · 2003 · International Journal of Clinical Practice